BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24118596)

  • 21. Molecular basis of hereditary factor V deficiency in India: identification of four novel mutations and their genotype-phenotype correlation.
    Chapla A; Jayandharan GR; Sumitha E; Sankari Devi G; Shenbagapriya P; Nair SC; Viswabandya A; George B; Mathews V; Srivastava A
    Thromb Haemost; 2011 Jun; 105(6):1120-3. PubMed ID: 21647534
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological studies in combined factor V and factor VIII deficiency.
    Giddings JC; Seligsohn U; Bloom AL
    Br J Haematol; 1977 Oct; 37(2):257-64. PubMed ID: 603759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in management of unusual acquired factor V deficiency: A case report.
    Takemoto K; Hamada O; Kitamura K; Fujiwara N; Miyakawa Y
    Medicine (Baltimore); 2019 Apr; 98(17):e15259. PubMed ID: 31027075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of an asymptomatic idiopathic inhibitor to coagulation factor V.
    Lucia JF; Aguilar C
    Haemophilia; 2005 Mar; 11(2):178-80. PubMed ID: 15810922
    [No Abstract]   [Full Text] [Related]  

  • 26. [Factor V inhibitor: case report and literature review].
    Dubois-Galopin F; Lebreton A; Marques-Verdier A; Ruivard M; Berger M; Serre-Sapin AF
    Ann Biol Clin (Paris); 2011; 69(2):217-22. PubMed ID: 21464017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis.
    Ghachem I; El Borgi W; Fekih Salem S; Ben Lakhal F; Chelbi A; Ghiriani I; Gouider E
    Ann Biol Clin (Paris); 2020 Apr; 78(2):206-209. PubMed ID: 32319951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel treatment of combined factor V and factor VIII deficiency with Factor Eight Inhibitor Bypass Activity.
    Olaiya O; Amos LE; Carpenter SL
    Haemophilia; 2020 Jan; 26(1):e21-e22. PubMed ID: 31778262
    [No Abstract]   [Full Text] [Related]  

  • 29. The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency.
    Breederveld K; Giddings JC; ten Cate JW; Bloom AL
    Br J Haematol; 1975 Mar; 29(3):405-12. PubMed ID: 1103945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroids.
    Patel MD; Hajdenberg J
    Haemophilia; 2016 May; 22(3):e231-2. PubMed ID: 27029965
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitation of coagulant antigens and inhibition of activated protein C in combined factor V VIII deficiency.
    Giddings JC; Sugrue A; Bloom AL
    Br J Haematol; 1982 Nov; 52(3):495-502. PubMed ID: 6812616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery anomaly with congenital factor V deficiency.
    Faisal AW; Hameed S; Ahmad W; Latif M
    J Pak Med Assoc; 2008 Nov; 58(11):650-1. PubMed ID: 19024144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.
    Cui QY; Shen HS; Wu TQ; Chen HF; Yu ZQ; Wang ZY
    Drug Des Devel Ther; 2015; 9():2395-8. PubMed ID: 25987837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired Factor V Deficiency Associated with CFPM Administration.
    Yamanishi M; Nishimi Y; Usui M; Miki K; Imashuku S
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency.
    Lee WS; Chong LA; Begum S; Abdullah WA; Koh MT; Lim EJ
    J Pediatr Hematol Oncol; 2001 May; 23(4):244-6. PubMed ID: 11846304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired factor V inhibitor and single exposure to autologous growth factor.
    Shah AK; Moreno-Aspitia A
    Thromb Res; 2005; 116(1):87-9. PubMed ID: 15850612
    [No Abstract]   [Full Text] [Related]  

  • 37. [Factor V].
    Amano K; Fukutake K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():632-5. PubMed ID: 15658409
    [No Abstract]   [Full Text] [Related]  

  • 38. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
    Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
    Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acquired combined deficiency of Factor V and VIII].
    Khammassi N; Mohsen D; Abdelhedi H; Cherif O
    Tunis Med; 2013 Apr; 91(4):291-2. PubMed ID: 23673718
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acquired inhibitor to coagulation factor V].
    Takahashi I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):506-8. PubMed ID: 9833556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.